Fairhaven Wealth Management, LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.

Quarter-by-quarter ownership
Fairhaven Wealth Management, LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2021$1,429,000
-11.2%
48,474
+2.3%
0.59%
-8.3%
Q2 2021$1,610,000
-3.4%
47,381
-7.5%
0.64%
-8.2%
Q1 2021$1,666,000
-13.3%
51,248
-3.9%
0.70%
-17.4%
Q4 2020$1,921,000
-8.7%
53,329
-0.7%
0.85%
-32.0%
Q3 2020$2,103,000
+115.3%
53,694
+101.5%
1.24%
+93.6%
Q2 2020$977,00026,6470.64%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$20,220,00066.82%
Baymount Management LP 145,000$3,970,00028.08%
New Harbor Financial Group, LLC 1,371,341$37,547,00018.51%
New Harbor Financial Group, LLC 1,291,700$35,366,00017.44%
MKP Capital Management, L.L.C. 1,500,000$41,070,00013.74%
Windmill Hill Asset Management Ltd 844,600$23,125,00011.94%
Hollow Brook Wealth Management LLC 768,567$21,043,00011.57%
Grand Central Investment Group 261,915$7,171,00010.33%
Point72 Europe (London) LLP 1,467,000$40,166,0008.50%
Slate Path Capital LP 4,600,000$125,948,0007.87%
View complete list of VANECK VECTORS ETF TR shareholders